Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma-Reference-Cited by-同舟云学术

Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma

Published:2019 Issue:1 Volume:7 Page:196-210
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Wang Yang¹²³⁴,Sui Guoqing¹²³⁴,Teng Dengke¹²³⁴,Wang Qimeihui¹²³⁴,Qu Jia¹²³⁴,Zhu Lingyu¹²³⁴,Ran Haitao⁵⁶⁴^ORCID,Wang Zhigang⁵⁶⁴,Jin Chunxiang¹²³⁴,Wang Hui¹²³⁴^ORCID

Affiliation:

1. Department of Ultrasound

2. China-Japan Union Hospital of Jilin University

3. Changchun

4. P. R. China

5. Institute of Ultrasound imaging of Chongqing Medical University

6. Chongqing 400010

Abstract

This study provides an efficient theranostic strategy for concurrent targeted ultrasound molecular imaging and effective synergistic antitumor therapy.

Funder

National Natural Science Foundation of China

Ministry of Science and Technology of the People's Republic of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2019/BM/C8BM00970H

Reference77 articles.

1. Mediating Tumor Targeting Efficiency of Nanoparticles Through Design

2. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies